Guess which ASX cannabis share just rocketed 30% – The Motley Fool Australia

ASX 200
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Cronos posts earnings today.
Image source: Getty Images
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
The Cronos Australia Ltd (ASX: CAU) share price is pushing higher today following the release of its quarterly activities report for the quarter ended 30 June 2022.
The ASX cannabis share has since rocketed 32% into the green from the open and now trades at 29 cents apiece.
Key takeouts from the period include:
Sales generated through the CanView platform in the June quarter totalled roughly $21 million.
This results in a quarterly compound average growth rate (CAGR) of 34% for sales made through the CanView platform, the company says.
Average gross margins are also steady between 35–40% across the portfolio. Cronos says it now has more than 160 product stock keeping units (SKUs) sold on the platform.
It sold around 165,000 units through the CanView platform last quarter. This brings the total number
for FY22 to more than 486,000.
As a result, total units sold through CanView grew by 355,000 from FY21, a YoY growth of 270%.
Finally, another 203 new pharmacies established wholesale accounts through the CanView platform. This takes the cumulative number of pharmacies at year end to 2,808.
This is “close to half of all pharmacies in Australia,” Cronos says.
Speaking on the announcement, Cronos CEO, Rodney Cocks said:
At the end of the first financial year after our successful merger with CDA Health, we are very pleased to close out the year with total cash receipts of nearly $70 million, positive net operating cash flows of $13 million and more than $16 million in cash. Our CanView platform has been key to these results and is the sales and distribution partner of choice for leading Australian Medicinal Cannabis suppliers.
Having now established nationwide coverage of pharmacies, we look to execute the next phase of our growth strategy with our national Medical Science Liaison team targeting further prescribers across the country. As we continue to implement our strategic plan, we are confident of delivering further sustainable growth and shareholder value in 2023.
The merger with CDA Health Pty Ltd has resulted in a significant increase in Cronos’ expenditures. It has scaled up operations and therefore costs, as well.
It has retained positive net cash flows from operations for all four quarters of FY22. It is anticipated
that “the balance of the Group’s cash and cash equivalents is expected to increase over time.”
The ASX cannabis share is up 141% in the past 12 months.
Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
August 18, 2022 | Aaron Teboneras
What did Blackmores announce in its FY 2022 results?
Read more »
August 18, 2022 | Matthew Farley
A solid jump in profits in FY22 wasn’t enough to excite investors.
Read more »
August 18, 2022 | James Mickleboro
Nuix shares dropped into the red on Thursday…
Read more »
August 18, 2022 | Aaron Teboneras
How did Codan track for the 2022 financial year?
Read more »
August 18, 2022 | Matthew Farley
The gold miner’s shares are slumping following the release of the company’s FY22 results
Read more »
August 18, 2022 | Mitchell Lawler
Here’s how Pro Medicus dialled up the profits in FY22.
Read more »
August 18, 2022 | Bernd Struben
The Canadian based acquisition marks the first expansion for IPH beyond the Asia Pacific region.
Read more »
August 18, 2022 | Matthew Farley
The REIT’s share price is lower today despite a significant earnings increase.
Read more »
View All
In this FREE STOCK REPORT, Scott Phillips, and his team at Motley Fool’s Share Advisor have released a special free report, detailing 5 ASX stocks that they think could be fantastic stocks to own as investors prepare for their retirement.
Sign Up for Take Stock
Investment news, stock ideas, and more, straight to your inbox.
Get Started Investing
You can do it. Learn about investing with our Investing Education hub.
Win at Retirement
Our latest articles and strategies for the post-work life you want.
Listen to Our Podcast
Hear our experts take on shares, the market & how to invest.
Join Our Premium Community
Join our flagship membership service, Share Advisor.
To make the world Smarter, Happier, And Richer
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show and premium investing services. The Motley Fool launched its Australian presence in 2011, and since then has grown to reach over 1 million Australians.
Read more about us >

This Service provides only general, and not personalised financial advice, and has not taken your personal circumstances into account. The Motley Fool Australia operates under AFSL 400691. For more information please see our Financial Services Guide. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. The Motley Fool Australia does not guarantee the performance of, or returns on any investment.
© 2010 – 2021 The Motley Fool Australia Pty Ltd. All rights reserved.
ACN: 146 988 052
Australian Financial Services Licence (AFSL): 400691
The Motley Fool Australia, PO Box 104, Isle of Capri, Qld 4217
Contact Details:
Phone: (03) 8592 4841
Email: [email protected]
Our friendly customer service team will happily get back to you as soon as they can.



Buy Weed In Australia

Articles: 148

Leave a Reply

Your email address will not be published.